Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 25.04.2024
SFS Group Schweiz AG
SFS Group Schweiz AG
/ Key word(s): AGMEGM
SFS receives approval for all proposals at the 2024 Annual General Meeting
25.04.2024 / 06:51 CET/CEST
The shareholders approved all proposals of the Board of Directors at the 31st Annual General Meeting of the SFS Group. The General Meeting conducted its first vote on the Sust [ … ]
Thu, 25.04.2024
SNP Schneider-Neureither & Partner SE
Corporate News
After Record Year 2023 SNP Starts with the Best First Quarter Ever
Group revenue increased by 15% to €54.0 million in Q1 2024 (Q1 2023: €47.1 million)
EBIT rose by 63% to €4.0 million (Q1 2023: €2.5 million), EBIT margin to 7.4% (Q1 2023: 5.2%)
Operating cashflow turned significantly positive, totaling to €10.3 million (Q1 2023: [ … ]
Thu, 25.04.2024
Redcare Pharmacy N.V.
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
Group sales of EUR 560M in Q1, up 51% from prior year.
Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns.
Adj. EBITDA ma [ … ]
Thu, 25.04.2024
Bucher Industries AG
Bucher Industries AG
/ Key word(s): Quarterly / Interim Statement
Sales below the prior-year period with weaker market momentum, as expected 25.04.2024 / 06:00 CET/CEST
As expected, Bucher Industries' markets weakened over the course of the first quarter of 2024 in line with the general economic slowdown. The agricultural mac [ … ]
Wed, 24.04.2024
MorphoSys AG
Media Release
Planegg/Munich, Germany, April 24, 2024
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
Additional ASCO 2024 poster presentation will include new findings from the Phase 2 study of tulmimetostat
MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced th [ … ]
Wed, 24.04.2024
Cherry SE
Munich, 24. April 2024 - Cherry SE corrects old assumptions about the company's development and carries out conservative, non cash-effective revaluations
Cherry SE is recognizing asst impairments in the 2023 annual financial statements. These non-cash items relate to intangible assets, mainly goodwill, as well as property, plant and equipment and [ … ]
Wed, 24.04.2024
SIMONA Aktiengesellschaft
EBIT close to prior-year record – Group revenue down 16% on the back of sluggish global economy – Muted start to 2024
Kirn, 24 April 2024. In what proved to be a dynamic year, the SIMONA Group recorded solid earnings against the backdrop of difficult global economic conditions. Group revenue fell by 15.7 per cent to €600.0 million amid weak demand. [ … ]
Wed, 24.04.2024
Edison Investment Research Limited
London, UK, 24 April 2024
Edison issues initiation on International Public Partnerships (INPP): Consistently and responsibly delivering
International Public Partnerships’ (INPP’s) FY23 results show that it continues to deliver consistent and predictable returns for investors, while delivering environmental and social benefits for the indivi [ … ]
Wed, 24.04.2024
Cembra Money Bank AG
Cembra Money Bank AG
/ Key word(s): AGMEGM
Cembra shareholders approve all proposals of the Board of Directors
24.04.2024 / 15:55 CET/CEST
Zurich, 24 April 2024 – The Annual General Meeting 2024 of the Swiss bank Cembra was held in Zurich today. 304 shareholders attended the meeting, representing 14,665,422 registered s [ … ]
Wed, 24.04.2024
ElringKlinger AG
Minister-President Winfried Kretschmann visits ElringKlinger
Tour of the competence center for battery technology in Neuffen
Intensive exchange with ElringKlinger CEO Thomas Jessulat on the transformation of the automotive and supplier industry
Symbolic groundbreaking ceremony for new logistics center at the Neuffen plant
Dettingen/Erms (Germany [ … ]